Literature DB >> 7715340

HIV-1 subtypes and male-to-female transmission in Thailand.

C Kunanusont1, H M Foy, J K Kreiss, S Rerks-Ngarm, P Phanuphak, S Raktham, C P Pau, N L Young.   

Abstract

We examined the risk factors for heterosexual transmission of HIV in a case-control study of couples in Thailand. 90 HIV-positive men and their regular sex partners were enrolled at the immune clinic, Chulalongkorn Hospital, where 92% of male index cases had HIV-1 serotype A (subtype E). Most index cases had acquired HIV through sexual intercourse. 95 couples were enrolled at 15 detoxification clinics, where 79% of them had HIV-1 serotype B (subtype B). Most men had acquired HIV through injecting drug use (IDU).

Entities:  

Keywords:  Asia; Behavior; Biology; Case Control Studies; Couples; Developing Countries; Diseases; Drug Usage; Family And Household; Family Characteristics; Heterosexuals; Hiv; Hiv Infections--transmission; Iv Drug Users; Research Report; Risk Factors; Sex Behavior; Southeastern Asia; Studies; Thailand; Viral Diseases

Mesh:

Year:  1995        PMID: 7715340     DOI: 10.1016/s0140-6736(95)90818-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

Review 1.  Global impact of human immunodeficiency virus and AIDS.

Authors:  H D Gayle; G L Hill
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Predicting the level of vaccine-induced cross-immunity necessary to eliminate HIV epidemics composed of multiple subtypes.

Authors:  David J Gerberry; Sally Blower
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

3.  Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes.

Authors:  M A Montano; V A Novitsky; J T Blackard; N L Cho; D A Katzenstein; M Essex
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 4.  Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.

Authors:  Holly Janes; Lawrence Corey; Gita Ramjee; Lindsay N Carpp; Carl Lombard; Myron S Cohen; Peter B Gilbert; Glenda E Gray
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-19       Impact factor: 2.205

5.  Integrating laboratory and epidemiological techniques for population-based surveillance of HIV strains and drug resistance in Canada.

Authors:  G C Jayaraman; C P Archibald; L Lior; D Sutherland
Journal:  Can J Infect Dis       Date:  2000-03

6.  env Gene typing of human immunodeficiency virus type 1 strains on electronic microarrays.

Authors:  N A Saunders; S Alexander; I Tatt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

7.  Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism.

Authors:  M Pope; S S Frankel; J R Mascola; A Trkola; F Isdell; D L Birx; D S Burke; D D Ho; J P Moore
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

8.  Recent aspects of HIV and HIV-related diseases.

Authors:  L Gürtler
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

9.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

10.  Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men.

Authors:  David M Butler; Davey M Smith; Edward R Cachay; George K Hightower; Charles Thomas Nugent; Douglas D Richman; Susan J Little
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.